US Broker Ratings

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking the 208% Potential Upside

Biohaven Ltd. (NYSE: BHVN), a key player in the biotechnology sector, is capturing investor attention with its substantial 208.64% potential upside, according to analyst ratings. Amidst..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Unveiling a Potential 123.75% Upside

For investors exploring opportunities in the biopharmaceutical sector, Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling case with its promising potential upside and strategic focus on..

Adaptive Biotechnologies (ADPT) Stock Analysis: Unraveling Its Revenue Growth and Analyst Ratings

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the healthcare sector, is making waves in the biotechnology industry with its cutting-edge immune medicine platform. Headquartered..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a 37.85% Potential Upside

Omnicell, Inc. (OMCL), a prominent player in the healthcare sector, specializes in providing innovative medication management solutions and adherence tools. With a market capitalization of $1.53..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 31.61% Potential Upside in the Biotech Sector

Arcellx, Inc. (ACLX) is carving a niche in the biotechnology landscape, offering promising therapeutic solutions particularly in the realm of cancer treatment. As of today, the..

BGM Group Ltd. (BGM): Investor Outlook Amidst Revenue Challenges and Strategic Opportunities

BGM Group Ltd. (BGM), a key player in China’s healthcare sector, primarily operates within the Drug Manufacturers – Specialty & Generic industry. With a market capitalization..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Powerhouse with Over 100% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents a compelling case. With a robust pipeline of innovative treatments and a..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A Biotech Contender with Over 100% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing investor attention in the biotechnology arena with a market cap of $1.89 billion. The company, based in Boulder, Colorado,..

Amneal Pharmaceuticals (AMRX) Investor Outlook: Analyzing the 20.59% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) stands poised at an intriguing juncture for investors, with a 20.59% potential upside based on current analyst ratings. As a leading..

Disc Medicine, Inc. (IRON) Investor Outlook: Exploring a 30% Potential Upside in the Biotech Arena

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, stands at the forefront of pioneering therapies for serious hematologic diseases. With a..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 43% Potential Upside in Biotechnology

Investors eyeing the biotechnology sector may find Dyne Therapeutics, Inc. (DYN) an intriguing prospect, particularly with its impressive potential upside of 43.22%. This clinical-stage company, headquartered..

Organon & Co. (OGN) Investor Outlook: Analyzing a 61.45% Potential Upside Amidst Mixed Ratings

For investors looking to navigate the complex landscape of the healthcare sector, Organon & Co. (NYSE: OGN) offers a unique mix of opportunities and challenges. With..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 65% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, has piqued the interest of investors with its robust growth metrics and strategic positioning..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook on a Biotech with 192.87% Potential Upside

Investors are eyeing BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) with keen interest, as the biotechnology firm presents an intriguing opportunity within the healthcare sector. Known for developing..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A 61.73% Potential Upside for Biotech Investors

Scholar Rock Holding Corporation (NASDAQ: SRRK), a biotechnology company headquartered in Cambridge, Massachusetts, is garnering significant attention in the healthcare sector. Known for its innovative approach..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unpacking the Biotech Player with a Robust Revenue Growth

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector as a compelling investment opportunity, particularly for those captivated by the healthcare industry’s dynamic landscape...

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Navigating a 17.92% Potential Upside in the Biotech Sector

For investors eyeing innovation in the healthcare sector, Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) represents an intriguing opportunity. With a focus on rare and orphan diseases, Mirum..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator with 2.34% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotech firm, has been making waves in the healthcare sector with its innovative approach to developing antibody therapeutics. Despite the..

Harmony Biosciences Holdings, Inc. (HRMY): A Biotechnology Stock with 50% Upside Potential

For investors seeking opportunities in the healthcare sector, Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out as a compelling candidate, particularly in the biotechnology industry. With..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 53% Upside Potential in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a trailblazer in the biotechnology sector, is capturing investor attention with its focus on precision medicine in oncology. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds